BG
WX

BlackRock Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BlackRock Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,061,509
Closed -$45.9M – 3099
2015
Q3 		$45.9M Sell
1,061,509
-506,926
-32% -$21.4M 0.03% 593
2015
Q2 		$66.3M Buy
1,568,435
+628,616
+67% +$26.5M 0.04% 508
2015
Q1 		$36.4M Sell
939,819
-136,987
-13% -$5.28M 0.02% 672
2014
Q4 		$36.3M Buy
1,076,806
+139,724
+15% +$4.93M 0.02% 666
2014
Q3 		$32.8M Buy
937,082
+230,116
+33% +$7.89M 0.02% 671
2014
Q2 		$23.2M Buy
706,966
+81,553
+13% +$2.79M 0.01% 753
2014
Q1 		$23.1M Sell
625,413
-91,358
-13% -$3.35M 0.01% 744
2013
Q4 		$27.5M Sell
716,771
-920,064
-56% -$29M 0.02% 680
2013
Q3 		$44.8M Sell
1,636,835
-326,516
-17% -$7.74M 0.03% 573
2013
Q2 		$41.2M Buy
+1,963,351
New +$38.3M 0.03% 550

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

BlackRock Group's WX Position: Q4 2015 in Review

BlackRock Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,061,509 shares — an estimated $45.9M sold.

BlackRock Group first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $66.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • BlackRock Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • BlackRock Group sold 1,061,509 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $45.9M.
  • BlackRock Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • BlackRock Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $66.3M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on BlackRock Group's 13F filing for Q4 2015, filed 11 Feb 2016.